Gts Securities LLC Sangamo Therapeutics, Inc Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$0.32 - $1.1 $4,480 - $15,400	14,000 Added 67.96%	34,600 $29,000
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $1,620 - $2,925	4,500 Added 27.95%	20,600 $7,000
Q1 2024 May 15, 2024	BUY	$0.42 - $1.38 $1,596 - $5,244	3,800 Added 30.89%	16,100 $10,000
Q4 2023 Feb 14, 2024	SELL	$0.3 - $0.63 $1,200 - $2,520	-4,000 Reduced 24.54%	12,300 $6,000
Q3 2023 Nov 15, 2023	BUY	$0.58 - $1.47 $9,454 - $23,961	16,300 New	16,300 $9,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $441M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.